Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

A-072

Atenolol solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
1 mL
Check Cart for Availability
$50.00

About This Item

Empirical Formula (Hill Notation):
C14H22N2O3
CAS Number:
29122-68-7
Molecular Weight:
266.34
UNSPSC Code:
41116107
MDL number:
MFCD00057645
NACRES:
NA.24
EC Number:
200-835-2

$50.00

Check Cart for Availability
​
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

certified reference material

Quality Level

300

form

liquid

feature

SNAP-N-SPIKE®, SNAP-N-SHOOT®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in acetonitrile

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

2-8°C

SMILES string

CC(C)NCC(O)COc1ccc(CC(N)=O)cc1

InChI

1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)

InChI key

METKIMKYRPQLGS-UHFFFAOYSA-N

Gene Information

human ... ADRB1(153)

General description

Atenolol, commonly sold under the trade name Tenormin®, is a beta blocker used to treat a number of cardiac conditions from hypertension to angina. This Snap-N-Spike® Reference Solution is suitable for use in atenolol methods by LC/MS or GC/MS for applications such as clinical toxicology, forensic analysis, or pharmaceutical research.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Tenormin is a registered trademark of Astrazeneca UK

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
PHR1909A13400001044403
Atenolol solution 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

A-072

Atenolol solution

Atenolol Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1909

Atenolol

Atenolol European Pharmacopoeia (EP) Reference Standard

A1340000

Atenolol

Atenolol United States Pharmacopeia (USP) Reference Standard

USP

1044403

Atenolol

application(s)

clinical testing

application(s)

pharmaceutical

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

technique(s)

-

technique(s)

-

technique(s)

-

form

liquid

form

powder

form

-

form

-

Quality Level

300

Quality Level

300

Quality Level

-

Quality Level

-

grade

certified reference material

grade

certified reference material, pharmaceutical secondary standard

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

storage temp.

2-8°C

storage temp.

2-30°C

storage temp.

2-8°C

storage temp.

-

Still not finding the right product?

Explore all of our products under Atenolol solution

pictograms

FlameExclamation mark
GHS02,GHS07

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

35.6 °F - closed cup

flash_point_c

2 °C - closed cup

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hsin-Hui Chiu et al.
Mayo Clinic proceedings, 88(3), 271-276 (2013-01-17)
To assess the tolerability and efficacy of the investigational use of the angiotensin II receptor blocker losartan added to β-blockade (BB) to prevent progressive aortic root dilation in patients with Marfan syndrome (MFS). Between May 1, 2007, and September 31
Alfredo Carlo Altamura et al.
Expert opinion on drug metabolism & toxicology, 9(4), 423-440 (2013-01-22)
Anxiety disorders are considered the most common mental disorders and they can increase the risk for comorbid mood and substance use disorders, significantly contributing to the global burden of disease. For this reason, anxiolytics are the most prescribed psychoactive drugs
Ronald V Lacro et al.
American heart journal, 165(5), 828-835 (2013-04-30)
The Pediatric Heart Network designed a clinical trial to compare aortic root growth and other short-term cardiovascular outcomes in children and young adults with Marfan syndrome randomized to receive atenolol or losartan. We report here the characteristics of the screened
View All Related Papers

Global Trade Item Number

SKUGTIN
A-072-1ML04061833326220

Questions

Reviews

No rating value

Active Filters